Federal Circuit Keeps Takeda's Win Streak Alive
In its opinion, the U.S. Court of Appeals for the Federal Circuit rejected the obviousness argument put forth by generic drug maker Alphapharm Pty. Ltd.
“Based on the record before us, we conclude that the district court's fact-findings were not clearly erroneous and were supported by evidence in the record,” Judge Alan D....
To view the full article, register now.